newsfilter
← Latest News
Business Wire·

Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that the Company will release its financial